MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$39,025K
(-500.85%↓ Y/Y)
Other income, net
$1,118K
(-20.65%↓ Y/Y)
Loss from operations
-$21,181K
(-17.91%↓ Y/Y)
Change in fair value of
warrant liabilities
$18,962K
Total operating
expenses
$21,181K
(17.91%↑ Y/Y)
Research and development
$17,197K
(27.09%↑ Y/Y)
General and
administrative
$3,984K
(-10.13%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Eledon Pharmaceuticals, Inc. (ELDN)
Eledon Pharmaceuticals, Inc. (ELDN)